Tirzepatide has emerged as a groundbreaking therapy for type 2 diabetes, offering promising results. However, the price of this innovative drug and its supply have become key issues for patients and healthcare providers. While tirzepatide has been approved by regulatory agencies, its costly nature presents a significant challenge to many. Negotiat